lai_wang_beigene_leader

Lai Wang, Ph.D.

Global Head of R&D

Dr. Wang joined in BeiGene’s early days, in 2011. Currently the Global Head of R&D, his previous roles in the company have included heading the Discover Biomarkers and In VivoPharmacology groups and supporting clinical programs with the study of clinical biomarkers and translational research. He was appointed head of China Development in 2016, responsible for clinical development in the Asia-Pacific region.

Prior to joining BeiGene, Dr. Wang was the director of research at Joyant Pharmaceuticals, a biotech company based in Dallas, Texas.

Dr. Wang received his B.S. in 1996 from Fudan University and Ph.D. in 2001 from University of Texas Health Science Center at San Antonio. He completed his post-doc training with Dr. Xiaodong Wang at Howard Hughes Medical Institute.

You are now leaving BeiGene Australia


BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL